SUBSCRIBE
SUBSCRIBE
Biotech Bay

Aradigm Corporation Provides Further Comments On Restructuring And Cash Used In Operations

May 17, 2006 | 
1 min read

Aradigm Corporation (NASDAQ: ARDM) today is providing further comments on points made in the company’s recent financial press release and corresponding conference call.

MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: 3D image of a KRAS oncogene
Business
BridgeBio Spins Out Oncology Company with $200M in Financing
May 2, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: Bristol Myers Squibb office in California
Biotech Bay
BMS Taps Cellares in $380M CAR T Cell Therapy Manufacturing Agreement
April 22, 2024
 · 
2 min read
 · 
Tyler Patchen